Skip to content
10-Q

Quarterly Report

PMV PHARMACEUTICALS, INC. PMVP

0001193125-25-276003

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 53.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 52.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 52.32M sh
Shares Diluted Q3 2025 · Sep 30, 2024 51.57M sh
Shares Diluted Q3 2025 · Sep 30, 2024 51.5M sh
Capex Q3 2025 · Sep 30, 2025 $14K
Capex Q3 2025 · Sep 30, 2024 $599K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$56.39M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$34.62M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $36.34M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $40.88M
Stockholders Equity Q3 2025 · Sep 30, 2025 $121M
Stockholders Equity Q3 2025 · Jun 30, 2025 $140.61M
Stockholders Equity Q3 2025 · Mar 31, 2025 $160.11M
Stockholders Equity Q3 2025 · Dec 31, 2024 $176.08M
Stockholders Equity Q3 2025 · Sep 30, 2024 $197.91M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 $214.32M
Stockholders Equity Q3 2025 · Mar 31, 2024 $212.68M
Stockholders Equity Q3 2025 · Dec 31, 2023 $225.69M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.3M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.37M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.85M
Total Liabilities Q3 2025 · Dec 31, 2024 $15.21M
Current Assets Q3 2025 · Sep 30, 2025 $132.45M
Current Assets Q3 2025 · Dec 31, 2024 $175.66M
Total Assets Q3 2025 · Sep 30, 2025 $133.84M
Total Assets Q3 2025 · Dec 31, 2024 $191.29M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.40
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$0.40
Eps Basic Q3 2025 · Sep 30, 2025 −$1.14
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$0.69
Sga Expense Q3 2025 · Sep 30, 2025 $4.31M
Sga Expense Q3 2025 · Sep 30, 2025 $12.91M
Sga Expense Q3 2025 · Sep 30, 2024 $4.94M
Sga Expense Q3 2025 · Sep 30, 2024 $15.52M
Rd Expense Q3 2025 · Sep 30, 2025 $18.21M
Rd Expense Q3 2025 · Sep 30, 2025 $54.05M
Rd Expense Q3 2025 · Sep 30, 2024 $16.95M
Rd Expense Q3 2025 · Sep 30, 2024 $44.76M
Net Income Q3 2025 · Sep 30, 2025 −$21.06M
Net Income Q3 2025 · Sep 30, 2025 −$59.71M
Net Income Q3 2025 · Jun 30, 2025 −$21.21M
Net Income Q3 2025 · Mar 31, 2025 −$17.44M
Net Income Q3 2025 · Sep 30, 2024 −$19.23M
Net Income Q3 2025 · Sep 30, 2024 −$35.71M
Net Income Q3 2025 · Jun 30, 2024 −$1.21M
Net Income Q3 2025 · Mar 31, 2024 −$15.27M
Operating Income Q3 2025 · Sep 30, 2025 −$22.52M
Operating Income Q3 2025 · Sep 30, 2025 −$66.96M
Operating Income Q3 2025 · Sep 30, 2024 −$21.89M
Operating Income Q3 2025 · Sep 30, 2024 −$60.28M